USPSTF releases final research plan on TB screening

LabPulse.com staff writers
Jun 16, 2021
2019 12 03 00 00 5470 Tuberculosis Lungs 400

The U.S. Preventive Services Task Force (USPSTF) has posted its final research plan on screening for latent tuberculosis (TB) infection in adults. Assay tests are among the tools that USPSTF is evaluating for TB detection.

The draft research plan was posted for public comment from March 11 to April 7, 2021. The task force reviewed all submitted comments before finalizing the research plan. The next step is development of a draft recommendation statement.

Recommendations made by the USPSTF are independent of the U.S. government. The final research plan is available to view on the USPSTF website.

Latest in Guideline
Blood Test Samples Lab Social
ADLM releases guidance for blood lipid assessment, lipoprotein testing
September 4, 2024
Lung Cancer Hotspot Social
Upcoming lung cancer molecular testing guidelines address 7 questions
August 28, 2024
Body composition in patients treated with Ozempic
Sponsored
Body composition in patients treated with Ozempic
September 20, 2024
Fda Button Social
FDA releases final guidance on use of real-world data in regulatory submissions
July 25, 2024
Related Stories
Bacteria Mycobacterium Tuberculosis Social
Tuberculosis
Dielectrophoresis may enable the diagnosis of 'missing millions' of tuberculosis cases
Tuberculosis Lungs Social
Tuberculosis
USPSTF recommends screening for latent tuberculosis
2020 01 17 20 32 8969 Bacteria Mycobacterium Tuberculosis 400
Guideline
AI of chest x-rays finds TB when lab tests fall short
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Guideline
ADLM releases guidance for blood lipid assessment, lipoprotein testing
By LabPulse.com staff writers
Document outlines recommendations for standardizing clinical lipid testing workflows.
September 4, 2024
Blood Test Samples Lab Social
Upcoming lung cancer molecular testing guidelines address 7 questions
By Liz Carey
Revised guideline addresses next-generation sequencing and expanded biomarker testing.
August 28, 2024
Lung Cancer Hotspot Social
FDA issues draft guidance for PCCPs for medical devices
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has issued a draft guidance document for its proposed policies for predetermined change control plans (PCCPs) for medical devices.
August 23, 2024
Fda Sign Dc Social
FDA releases final guidance on use of real-world data in regulatory submissions
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) released its final guidance on using real-world data in regulatory submissions, detailing how drug companies should assess data from electronic health records and medical claims to support their applications.
July 25, 2024
Fda Button Social
FDA issues alert on BD vial supply shortage
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) is warning of a shortage of Becton Dickinson (BD) vials used to diagnose bacterial and fungal infections, suggesting that providers prioritize their use for patients with suspected bloodstream infections.
July 15, 2024
Lab Vacutainer Test Tube Social
FDA issues draft guidance on diversity in clinical study enrollment
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has issued a draft guidance document intended to assist medical product sponsors with improving enrollment of clinical study participants through Diversity Action Plans.
June 27, 2024
Fda Sign Dc Social
WHO launches new guidance on TB diagnostics
By LabPulse.com staff writers
The World Health Organization has published updated guidance for the diagnosis of tuberculosis (TB), including new recommendations on the use of next-generation sequencing for the diagnosis of drug-resistant TB.
March 21, 2024
Bacteria Mycobacterium Tuberculosis Social
FDA updates draft guidance for Alzheimer's drug development biomarkers
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has released an updated draft guidance for the use of biomarkers aimed at sponsors and pharmaceutical companies developing drugs intended to treat early Alzheimer's disease.
March 14, 2024
Amyloid Plaque Alzheimer Social
FDA orders new info warnings on CAR-T therapies
By LabPulse.com staff writers
Following its review of reports of T-cell malignancies associated with the administration of six CAR-T immunotherapies, the FDA has instructed the manufacturers to include warnings in the prescribing info for the therapeutics.
January 30, 2024
Fda Button Social
Labs and manufacturers face challenges with rollout of IVDR
By Matt Limb
Laboratories and medical device manufacturers have revealed how they face technical and workload challenges in gearing up to comply with stringent new European Union regulations.
October 2, 2023
Regulation Wheel Social
USP proposes synthetic alternative to horseshoe crab blood in endotoxin testing
By Nick Paul Taylor
The U.S. Pharmacopoeia (USP) has published draft guidelines on using a synthetic alternative to reagents derived from horseshoe crabs, advancing efforts to provide an alternative way of performing endotoxin testing.
August 31, 2023
Lab Blood Man Social
NGS working group provides recommendations for germline variant confirmation
By Elissa Wolfson
A joint report provides eight recommendations for standardizing orthogonal confirmation practices for germline variants detected by next-generation sequencing.
May 19, 2023
Dna Sequencing2 Social
Page 1 of 9
Next Page